UT Southwestern Medical Center researchers find that an FDA-approved drug to treat high blood pressure seems to extend life span in worms via a cell signaling pathway that may mimic caloric restriction.
The drug, hydralazine, extended life span about 25 percent in two strains of C. elegans (roundworms), one a wild type and the other bred to generate high levels of a neurotoxic protein called tau that in humans is associated with Alzheimer’s disease.
“This is the first report of hydralazine treatment activating the NRF2/SKN-1 signaling pathway. We found the drug extends the life span of worms as well as or better than other potential anti-aging compounds such as curcumin and metformin. The treatment also appeared to maintain their health as measured by tests of flexibility and wiggling speed,” said Dr. Hamid Mirzaei, Assistant Professor of Biochemistry at UT Southwestern and senior author of the study, published today in Nature Communications.
The NRF2 pathway protects human cells from oxidative stress. The body’s ability to protect itself against damaging oxygen free radicals diminishes with age, he said.
One of the hallmarks of aging and neurodegenerative diseases such as Alzheimer’s and Parkinson’s is oxidative stress, which is believed to result cumulatively from inflammatory and infectious illnesses throughout life, Dr. Mirzaei explained. SKN-1, a C. elegans transcription factor, corresponds to NRF2 in humans. Both play a pivotal role in their respective species’ responses to oxidative stress and life span, he said.
The UT Southwestern researchers were searching for a chemical probe they could use in experiments to identify proteins that get oxidized and become toxic during aging. Their screen for a substance that would cross the blood-brain barrier and be nontoxic led them to hydralazine.
“Age-related neurodegenerative diseases are devastating, and those conditions are on the rise due to the increase in the life span of humans. For that reason, it is important to develop treatments to maintain human health as long as possible,” said Dr. Mirzaei, who is also an investigator in the Center for Alzheimer’s and Neurodegenerative Diseases, part of the Peter O’Donnell Jr. Brain Institute at UT Southwestern.
The researchers did in vivo (in a living creature) and in vitro (in a lab dish) studies on the worms and also studied human cells from a pediatric cancer called neuroblastoma. Compared with untreated controls, roundworms treated with the drug showed about a 25 percent increase in life span (from 15-18 days to about 20-23 days), the team reported.
The results of a series of biochemical experiments indicated that the hydralazine-linked life span extension was dependent on the worms’ SKN-1 pathway via a mechanism that appeared to mimic caloric restriction, he said.
To test the potency of hydralazine in the context of neurodegenerative disease, the scientists used a high dose of a chemical stressor called rotenone that is associated with increased risk of Parkinson’s disease in humans exposed to high doses. They found that hydralazine provided a significant amount of neuroprotection, Dr. Mirzaei said. The drug also showed a significant decrease in tau toxicity in the C. elegansmodel of Alzheimer’s disease, he added.
“Based on these results, we suggest that hydralazine may be a good candidate for clinical trials for the treatment of age-related disorders in humans as it may also offer general health benefits to the aging population,” he said.
He stressed that this study is a promising first step, but further studies are needed to corroborate it.
The Latest on: Life extension
- ROCHE - RHHBY Life Extension Pharma Stocks Investingon August 15, 2019 at 2:48 am
We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on ...
- NSW mine life extension not approved: AQCon August 12, 2019 at 5:06 pm
Australian Pacific Coal says its application to extend the mine life at its Dartbrook coal mine in NSW has not been approved by a land use planning body. However, the coal miner said some elements ...
- Australian Pacific Coal disappointed that life extension for key coal mine deniedon August 12, 2019 at 6:19 am
Australian Pacific Coal mulls options after regulator bars mine extension By Melanie Burton MELBOURNE, Aug 13 (Reuters) - Australian Pacific Coal said on Tuesday it was considering its options after a ...
- Australian Pacific Coal says Dartboork mine life extension not approvedon August 12, 2019 at 5:20 am
Aug 13 (Reuters) - Australian Pacific Coal Ltd said on Tuesday that its application to extend the mine life at its Dartbrook coal mine in New South Wales had not been approved by a land use planning ...
- Population Prospects 2019 and Life Extensionon August 5, 2019 at 1:08 pm
A common concern about life extension is overpopulation, the idea that there are too many people in the world. Are we really headed for a global overpopulation meltdown, as some people believe? The ...
- Human Life Extension Investing in IBB - iShares Nasdaq Biotechnology ETF - IBBon July 27, 2019 at 9:17 am
We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the ...
- Bioethicist and Life Extension Opponent Daniel Callahan Has Diedon July 24, 2019 at 11:34 am
Few people can be said to have originated a new field of intellectual endeavor; pioneering bioethicist Daniel Callahan is one of those people. Callahan died yesterday at age 88. In the late 1960s, ...
- Reader's Digest Unveils Life Extension as First Sponsor of the Nationwide Search for the Nicest Places in Americaon July 20, 2019 at 10:15 pm
NEW YORK: Readers' Digest revealed today the first-ever sponsor for its Nicest Places in America program: Life Extension. Life Extension is the health solutions expert that is translating scientific ...
- Humanity Life Extension, LLC Announces The Humility® Cancer Treatment, a Breakthrough Metastatic Cancer Solutionon July 17, 2019 at 5:34 am
Today, Humanity Life Extension, LLC announced a breakthrough metastatic cancer treatment known as The Humility® Cancer Treatment. Doctors have known for many years that cancer dies at 107.6 degrees ...
via Google News and Bing News